Seguir
Paolo Ambrosino
Paolo Ambrosino
Dirección de correo verificada de unimol.it
Título
Citado por
Citado por
Año
Genotype–phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of Kv7. 2 potassium channel subunits
F Miceli, MV Soldovieri, P Ambrosino, V Barrese, M Migliore, MR Cilio, ...
Proceedings of the National Academy of Sciences 110 (11), 4386-4391, 2013
1982013
Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7. 2 and Kv7. 3 potassium channel subunits
F Miceli, MV Soldovieri, P Ambrosino, M De Maria, M Migliore, R Migliore, ...
Journal of Neuroscience 35 (9), 3782-3793, 2015
1812015
Activation and desensitization of trpv1 channels in sensory neurons by the peroxisome proliferator-activated receptor α agonist palmitoylethanolamide
P Ambrosino, MV Soldovieri, C Russo, M Taglialatela
British Journal of Pharmacology 168 (6), 1430-1444, 2013
146*2013
Novel KCNQ2 and KCNQ3 Mutations in a Large Cohort of Families with Benign Neonatal Epilepsy: First Evidence for an Altered Channel Regulation by Syntaxin‐1A
MV Soldovieri, N Boutry‐Kryza, M Milh, D Doummar, B Heron, E Bourel, ...
Human mutation 35 (3), 356-367, 2014
1182014
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels
LDC Mannelli, E Lucarini, L Micheli, I Mosca, P Ambrosino, MV Soldovieri, ...
Neuropharmacology 121, 49-59, 2017
1062017
The ever changing moods of calmodulin: how structural plasticity entails transductional adaptability
A Villarroel, M Taglialatela, G Bernardo-Seisdedos, A Alaimo, J Agirre, ...
Journal of molecular biology 426 (15), 2717-2735, 2014
1022014
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels
FA Iannotti, C Silvestri, E Mazzarella, A Martella, D Calvigioni, F Piscitelli, ...
Proceedings of the National Academy of Sciences 111 (24), E2472-E2481, 2014
952014
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain‐of‐function variant
JJ Millichap, F Miceli, M De Maria, C Keator, N Joshi, B Tran, ...
Epilepsia 58 (1), e10-e15, 2017
942017
Expression and function of Kv7. 4 channels in rat cardiac mitochondria: possible targets for cardioprotection
L Testai, V Barrese, MV Soldovieri, P Ambrosino, A Martelli, I Vinciguerra, ...
Cardiovascular research 110 (1), 40-50, 2016
852016
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy
F Rizzo, P Ambrosino, A Guacci, M Chetta, G Marchese, T Rocco, ...
Molecular and Cellular Neuroscience 72, 54-63, 2016
842016
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction
P Nappi, F Miceli, MV Soldovieri, P Ambrosino, V Barrese, M Taglialatela
Pflügers Archiv-European Journal of Physiology 472, 881-898, 2020
762020
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
V Barrese, F Miceli, MV Soldovieri, P Ambrosino, FA Iannotti, MR Cilio, ...
Clinical pharmacology: advances and applications, 225-236, 2010
682010
Early treatment with quinidine in 2 patients with epilepsy of infancy with migrating focal seizures (EIMFS) due to gain-of-function KCNT1 mutations: functional studies …
R Dilena, JC DiFrancesco, MV Soldovieri, A Giacobbe, P Ambrosino, ...
Neurotherapeutics 15 (4), 1112-1126, 2018
552018
Epilepsy-causing mutations in Kv7. 2 C-terminus affect binding and functional modulation by calmodulin
P Ambrosino, A Alaimo, S Bartollino, L Manocchio, M De Maria, I Mosca, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …, 2015
552015
Neurounina-1, a novel compound that increases Na+/Ca2+ exchanger activity, effectively protects against stroke damage
P Molinaro, M Cantile, O Cuomo, A Secondo, A Pannaccione, ...
Molecular Pharmacology 83 (1), 142-156, 2013
512013
De novo gain‐of‐function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy
P Ambrosino, MV Soldovieri, T Bast, PD Turnpenny, S Uhrig, S Biskup, ...
Annals of neurology 83 (6), 1198-1204, 2018
502018
T-type channel blocking properties and antiabsence activity of two imidazo [1, 2-b] pyridazine derivatives structurally related to indomethacin
MG Rimoli, E Russo, M Cataldi, R Citraro, P Ambrosino, D Melisi, ...
Neuropharmacology 56 (3), 637-646, 2009
472009
Pharmacological targeting of neuronal Kv7. 2/3 channels: a focus on chemotypes and receptor sites
F Miceli, MV Soldovieri, P Ambrosino, L Manocchio, I Mosca, ...
Current medicinal chemistry 25 (23), 2637-2660, 2018
462018
Tryptamine-based derivatives as transient receptor potential melastatin type 8 (TRPM8) channel modulators
A Bertamino, C Ostacolo, P Ambrosino, S Musella, V Di Sarno, T Ciaglia, ...
Journal of Medicinal Chemistry 59 (5), 2179-2191, 2016
462016
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7. 2 potassium channels to phosphatidylinositol 4, 5-bisphosphate
MV Soldovieri, P Ambrosino, I Mosca, M De Maria, E Moretto, F Miceli, ...
Scientific reports 6 (1), 38167, 2016
452016
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20